Results 111 to 120 of about 75,380 (266)

Pulmonary venous aneurysm presenting as a middle mediastinal mass.

open access: yes, 1996
A large mediastinal mass in a 43-year-old man was proven at thoracotomy to comprise a right superior pulmonary vein aneurysm. Intraoperative transesophageal echocardiography was useful in defining the abnormality.
Livolsi, V A   +5 more
core  

A Case of Acalculous Cholecystitis During Lenvatinib Plus Pembrolizumab Therapy for Advanced Renal Cell Carcinoma

open access: yesIJU Case Reports, Volume 9, Issue 4, July 2026.
ABSTRACT Introduction Lenvatinib plus pembrolizumab is a standard first‐line therapy for advanced renal cell carcinoma (RCC), and acute acalculous cholecystitis is a rare adverse event. Case Presentation A 60‐year‐old woman with metastatic TFE3‐positive non–clear cell RCC, classified as poor risk by the International Metastatic RCC Database Consortium (
Erika Soga   +9 more
wiley   +1 more source

Castleman's disease: An unusual cause of mediastinal mass and anemia

open access: yes, 2002
We reported a case of thoracic localized, mixed variant, Castleman's Disease (angiofollicular lymph node hyperplasia) with a favourable clinical course presenting with mediastinal mass, microcytic anemia, mild thrombocytosis, polyclonal ...
Scott C.   +6 more
core   +1 more source

Causes of Persistent ST Elevation in Patients With Lung Cancer: A Case Report

open access: yesAnnals of Noninvasive Electrocardiology, Volume 31, Issue 4, July 2026.
ST elevation without Q waves in advanced cancer may suggest cardiac metastasis; voltage gradient while repolarization may cause ST elevation in cardiac metastasis. ABSTRACT Cardiac metastases are rare in clinical practice. Herein, we describe the case of a 61‐year‐old male patient who underwent radical left lung cancer surgery > 2 years before the ...
Lijiang Ding, Huayong Jin
wiley   +1 more source

Extramedullary plasmacytoma presenting as a mediastinal mass

open access: yes, 2011
Extramedullary plasmacytoma (EMP) is a plasma cell neoplasm without bone marrow involvement or other systemic characteristics of multiple myeloma. Few large-scale clinical studies have been conducted because of the rarity of EMP, especially when it ...
Surinder Solanki   +6 more
core  

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 Trials

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5915-5925, July 2026.
ABSTRACT Aims Petrelintide is a long‐acting amylin analogue in development for weight management. The safety, tolerability, pharmacokinetics, and pharmacodynamics of petrelintide were evaluated in single ascending dose (SAD) and multiple ascending dose (MAD) trials. Materials and Methods Both trials were randomized, placebo‐controlled, and double‐blind.
Minna Brændholt Olsen   +6 more
wiley   +1 more source

Vanishing Mediastinal Mass

open access: yes
A 39-year-old man with no notable medical history was being examined because of a transient ischemic attack. On a chest radiograph, a mediastinal mass was detected when the patient was in the supine position (Panel A, arrow) but disappeared when he was ..
De Perrot, M.
core  

What's Your Diagnosis? Large Mediastinal Mass in a Dog

open access: yes
Veterinary Clinical Pathology, EarlyView.
Rosane O. Cruz   +7 more
wiley   +1 more source

Loncastuximab Tesirine in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma: Evidence and Practical Guidance From Italian Clinical Experience

open access: yesEuropean Journal of Haematology, Volume 117, Issue 1, Page 144-153, July 2026.
ABSTRACT Patients with relapsed/refractory (R/R) diffuse large B‐cell lymphoma (DLBCL) who progress to the third‐line setting face a lack of standardized treatment, despite the presence of multiple available therapies. In this context, antibody–drug conjugates represent a relatively new class of anticancer agents; among them, loncastuximab tesirine is ...
Francesca Bonello   +7 more
wiley   +1 more source

MEDIASTINAL GRAY ZONE LYMPHOMA; SHADES OF GRAY

open access: yesHematology, Transfusion and Cell Therapy
Objective: Mediastinal gray zone lymphoma (MGZL) is a rare B cell lymphoma originated from the thymic niche. An incostistency between morphological and immunohistochemical findings is the hallmark of the disease .
Meral Ulukoylu Menguc   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy